| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 430K | Jun 13, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Medical Officer |
| TCRX | TScan Therapeutics, Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | Chief Medical Officer |
| TCRX | TScan Therapeutics, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 7, 2022 | Chief Medical Officer |
| TCRX | TScan Therapeutics, Inc. | Jul 5, 2022 | 0 | $0 | 3 | Jul 7, 2022 | Chief Medical Officer |